MAPT and Cognitive impairment: One study in 2018 detailed how LRGT decreases tau pathology, reverses cognitive impairment in mice, and has a protective effect on insulin receptors and synapses in the brain via the activation of the protein kinase A (PKA) signaling pathways [34].